Skip to content

Compare medicines

Put up to three medicines side by side. Useful for alternatives in the same class, or for seeing how two very different treatments differ.

Attribute
In shortMonthly injection that blocks and degrades the oestrogen receptor.Aromatase inhibitor for breast cancer treatment and prevention.
Body systemCancerCancer
Drug classSelective oestrogen receptor degradersAromatase inhibitors
SupplyPrescription onlyWHO essential medicinePrescription onlyWHO essential medicine
Main usesHormone-receptor-positive advanced breast cancerBreast cancer after menopause, Breast cancer prevention (high risk)
How it worksBlocks oestrogen from stimulating breast cancer cells.Cuts oestrogen levels after menopause.
Starts workingDepends on the cancer and regimen—
Half-lifeAbout 40 daysAbout 50 hours
Typical adult doseDosed by your cancer team according to the treatment protocol.1 mg once a day.
FormsIntramuscular injectionTablet
Common side effectsInjection site pain, Hot flushes, Nausea, Tiredness, Joint painHot flushes, Joint pain, Tiredness
Serious side effectsLiver enzyme rise, Allergic reaction, Bruising and bleeding at injection siteBone thinning, Severe skin reactions (rare)
Don't take ifPregnancy; Severe liver impairment—
AlcoholUsually no problem in moderation. No specific interaction.—
PregnancyUsually avoidedAvoid.Usually avoidedNot for use in pregnancy.
BreastfeedingUsually avoidedAvoid.—
In use since—1995
Brand namesUnited States: FaslodexUnited Kingdom: FaslodexIndia: Faslodex, Fulvestrant (generic)United States: ArimidexUnited Kingdom: ArimidexIndia: Armotraz, Altraz
Legal statusUnited States: Prescription onlyUnited Kingdom: Prescription-only medicine (POM), hospital useIndia: Schedule H—
ATC codeL02BA03L02BG03

Taken together

No interaction between these medicines is recorded in the atlas.

Open in the interaction checker